Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
207.00    0.00 (0.00%)
Bid:
204.00
Ask:
207.00
Spread: 3.00 (1.471%)
Market Cap: £109.29m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Director/PDMR Shareholding

7 Sep 2011 15:15

RNS Number : 8227N
Microgen PLC
07 September 2011
 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

On 7 September 2011 David Sherriff, Chief Executive Officer of Microgen plc, acquired and subsequently sold 75,000 ordinary shares in Microgen plc. Mr Sherriff acquired the shares following the exercise of share options which were approaching their last date of exercise. This is Mr Sherriff’s first disposal of shares since joining the group on 3 May 1999 and he continues to hold 189,000 ordinary shares with interest in a further 768,381 ordinary shares under option details of which can be found in the 2010 Annual Report.Â

 

The following tables provide further details of the notification for Mr Sherriff and one further person discharging managerial responsibility.

 

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or

(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii)

MICROGEN PLC

(i)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

DAVID SHERRIFF

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

SEE 3 ABOVE

ORDINARY SHARES OF 5P EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

DAVID SHERRIFF

EXERCISE OF SHARE OPTIONS & SALE OF SHARES

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

75,000 SHARES

0.09%

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

75,000 SHARES

0.09%

13.

Price per share or value of transaction

14.

Date and place of transaction

50,000 SHARES PURCHASED AT AN OPTION PRICE OF 87.5 PENCE.

25,000 SHARES PURCHASE AT AN OPTION PRICE OF 42.5 PENCE.

75,000 SHARES SOLD AT A PRICE OF 154 PENCE.

7 SEPTEMBER 2011, UK

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

189,000 SHARES

0.23%

7 SEPTEMBER 2011

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

N/A

N/A

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

N/A

N/A

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

N/A

N/A

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY'S CURRENT ISSUED SHARE CAPITAL WHICH IS 81,316,094

PHILIP WOOD, DIRECTOR, MICROGEN PLC - 020 7496 8100

 

 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or

(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii)

MICROGEN PLC

(i)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

CLARE GROOM

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

SEE 3 ABOVE

ORDINARY SHARES OF 5P EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

CLARE GROOM

EXERCISE OF SHARE OPTIONS & SALE OF SHARES

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

60,000 SHARES

0.07%

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

60,000 SHARES

0.07%

13.

Price per share or value of transaction

14.

Date and place of transaction

20,000 SHARES PURCHASED AT AN OPTION PRICE OF 70.5 PENCE

40,000 SHARES PURCHASED AT AN OPTION PRICE OF 93 PENCE

60,000 SHARES SOLD AT A PRICE OF 154 PENCE

7 SEPTEMBER 2011, UK

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

46,851 SHARES

0.06%

7 SEPTEMBER 2011

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

N/A

N/A

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

N/A

N/A

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

N/A

N/A

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY'S CURRENT ISSUED SHARE CAPITAL WHICH IS 81,316,094

PHILIP WOOD, DIRECTOR, MICROGEN PLC - 020 7496 8100

 

 

 

Name and signature of duly authorised officer of issuer responsible for making notification

PHILIP WOOD

Date of notification: 7 SEPTEMBER 2011

www.microgen.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUGUPGBUPGGCM
Date   Source Headline
25th Oct 20217:00 amRNSBlock Listing Application
11th Oct 20217:00 amRNSAcquisition of MPP Global Solutions Limited
1st Oct 20217:00 amRNSNon-Executive Directorate and Committee Changes
28th Sep 202111:24 amRNSBlock listing Interim Review
17th Sep 20217:00 amRNSChange of Auditor
28th Jul 20217:00 amRNSInterim Results
16th Jul 20217:00 amRNSNotice of Results
6th Jul 202110:39 amRNSHolding(s) in Company
1st Jul 20217:00 amRNSTotal Voting Rights
15th Jun 20219:57 amRNSDirector Declaration
27th May 20218:20 amRNSDirector Declaration
6th May 20213:36 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20213:27 pmRNSHolding(s) in Company
4th May 20218:55 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSAppointment of Joint Broker
27th Apr 202111:28 amRNSResult of AGM
27th Apr 20217:00 amRNSAGM Statement
9th Apr 202111:14 amRNSHolding(s) in Company
29th Mar 20212:06 pmRNSBlock listing Interim Review
23rd Mar 202111:13 amRNSDirector/PDMR Shareholding
11th Mar 20214:44 pmRNSBlock Listing Application
2nd Mar 20217:00 amRNSNotice of Results
1st Mar 202112:36 pmRNSTotal Voting Rights
19th Jan 20217:00 amRNSTrading Update
6th Jan 20214:23 pmRNSHolding(s) in Company
4th Jan 20217:00 amRNSTotal Voting Rights
18th Dec 20209:13 amRNSHolding(s) in Company
1st Dec 202010:09 amRNSTotal Voting Rights
23rd Nov 20205:37 pmRNSHolding(s) in Company
28th Oct 20201:58 pmRNSDirector/PDMR Shareholding
29th Sep 20204:41 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
28th Sep 202010:48 amRNSBlock listing Interim Review
9th Sep 20204:24 pmRNSGrant of awards under Performance Share Plan
2nd Sep 20201:38 pmRNSDirector Declaration
11th Aug 202012:19 pmRNSDirector/PDMR Shareholding
29th Jul 20207:00 amRNSInterim Results
6th Jul 20207:23 amRNSHolding(s) in Company
6th Jul 20207:21 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSTrading Update and Notice of Results
11th Jun 20204:41 pmRNSSecond Price Monitoring Extn
11th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20204:35 pmRNSPrice Monitoring Extension
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSTotal Voting Rights
29th Apr 202012:16 pmRNSDisclosure of Rights attached to Ordinary Shares
28th Apr 202012:45 pmRNSResult of AGM
21st Apr 20207:00 amRNSCOVID-19 Update and AGM Arrangements
8th Apr 20205:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.